FDA Drugs recall ·

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg… recall

Recall number
D-0484-2026
Date
(initiated March 26, 2026)
Company / brand
Hetero Labs Limited (Unit V)
Unit V, Sy. No.: 439,440,441&458, Mahabubnagar, N/A, India
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
4,740 1,000-count bottles.
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10

Why was it recalled?

Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Batch # FD253967, Exp Date: 06/26/2027

Distribution

Nationwide in the USA.

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0484-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.